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Abstract
Rhinovirus (RV), a single-stranded RNA picornavirus, is the most frequent cause of asthma exacerbations. We previously
demonstrated in human bronchial epithelial cells that melanoma differentiation-associated gene (MDA)-5 and the adaptor
protein for Toll-like receptor (TLR)-3 are each required for maximal RV1B-induced interferon (IFN) responses. However, in
vivo, the overall airway response to viral infection likely represents a coordinated response integrating both antiviral and
pro-inflammatory pathways. We examined the airway responses of MDA5- and TLR3-deficient mice to infection with RV1B, a
minor group virus which replicates in mouse lungs. MDA5 null mice showed a delayed type I IFN and attenuated type III IFN
response to RV1B infection, leading to a transient increase in viral titer. TLR3 null mice showed normal IFN responses and
unchanged viral titers. Further, RV-infected MDA5 and TLR3 null mice showed reduced lung inflammatory responses and
reduced airways responsiveness. Finally, RV-infected MDA5 null mice with allergic airways disease showed lower viral titers
despite deficient IFN responses, and allergic MDA5 and TLR3 null mice each showed decreased RV-induced airway
inflammatory and contractile responses. These results suggest that, in the context of RV infection, binding of viral dsRNA to
MDA5 and TLR3 initiates pro-inflammatory signaling pathways leading to airways inflammation and hyperresponsiveness.
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Introduction
Rhinovirus (RV) is the most frequent cause of acute respiratory
tract infection in humans. RV infection is typically responsible for
upper respiratory symptoms including rhinorrhea, sore throat,
nasal congestion, sneezing, cough, and headache. More impor-
tantly, RV has emerged as the most frequent pathogen associated
with exacerbations of asthma [1,2].
RV is a positive sense single-stranded RNA (ssRNA) virus from
the Picornaviridae family. After endocytosis, RV RNA is inserted
into the cytosol, where viral replication occurs. During replication,
a double-stranded RNA (dsRNA) intermediate is formed which
represents an important stimulus of the host innate immune
response. The mechanisms by which RV causes asthma
exacerbations are not fully established, but current evidence
indicates that the immune response is critical in this process. The
first line of defense against RV infection is the innate immune
system. Innate pathogen sensors detect viral products and respond
by initiating a signaling cascade that leads to a rapid antiviral
response involving secretion of interferons (IFNs) and inflamma-
tory cytokines. RV induces the expression of both type I (e.g., IFN-
a, IFN-b) and type III IFNs (in mice, IFN-l2/IL-28A, IFN-l3/
IL-28B). Though they signal through the engagement of different
receptor complexes, the intracellular signaling program activated
by type I and type III IFNs is very similar, as evidenced by the
cellular gene expression profiles induced after stimulation with
IFN-l versus IFN-a [3]. However, whereas the type I receptor
complex is expressed ubiquitously, the type III receptor is only
expressed in few cell types, notably epithelial cells [4]. The
preferential expression of IFN-l receptors on epithelial surfaces
may allow the host to rapidly control and perhaps eliminate
viruses at the major portals of entry into the body before infection
is established, and without activating other arms of the immune
system.
Several pattern recognition receptors have been shown to be
responsible for binding viral dsRNA and initiating the IFN
response. Retinoic acid inducible gene (RIG)-I and melanoma
differentiation-associated gene (MDA)-5 are homologous proteins
located within the cytoplasm, whereas Toll-like receptor (TLR)-3
is located mainly on the endosomal membrane and plasma
membrane. RIG-I has been shown to preferentially recognize 59
phosphorylated short dsRNA, whereas MDA5 recognizes long
dsRNAs [5,6,7,8]. Thus, RIG-I has been shown to detect
negative-strand viruses such as influenza, respiratory syncytial
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flaviviruses. In comparison, MDA5 has been shown to selectively
detect positive-strand viruses including picornaviruses (encephalo-
myocarditis virus, Mengo virus and Theiler’s virus). Previously, we
demonstrated in cultured human bronchial epithelial cells that
MDA5 and TIR-domain-containing adapter inducing interferon-
b (TRIF), the adaptor protein for TLR3, are each required for
maximal RV1B-induced IFN responses [10]. Knockdown of RIG-
I had no effect on IFN responses. TRIF, but not MDA5, was
required for maximal pro-inflammatory cytokine expression [10].
TLR3 is partially required for HRV39-induced IL-8 expression in
16HBE14o- human bronchial epithelial cells [11], as well as
HRV1A-induced MUC5AC expression in NCI-H292 mucoepi-
dermoid carcinoma cells [12].
However, in vitro studies may not truly represent the complicated
situation in vivo, where multiple cell types are involved. Further, the
overall airway response to viral infection likely represents a
coordinated response integrating both antiviral and pro-inflam-
matory pathways. For example, it has been proposed that
asthmatics are susceptible to RV infection due to deficient IFN
production. RV-infected airway epithelial cells from asthmatic
subjects show impaired production of IFN-b and -l [13,14] and
asthmatics experimentally infected with RV16 showed a reduced
IFN-c/IL-5 mRNA ratio in their sputum [15]. According to the
theory, reduced IFN responses, in turn, lead to increased viral-
mediated inflammation. However, it is also conceivable that
reduced RV-induced IFN responses are coupled with attenuated
airways inflammation and responsiveness. For example, pneumo-
virus-infected IFNa/b receptor null mice show fewer BAL
leukocytes and prolonged survival despite increased virus titers
[16]. To address these questions, we examined the airway
responses of TLR3- and MDA5-deficient mice to infection with
RV1B, a minor group virus which replicates in mouse lungs [17].
Results
Effects of MDA5 and TLR3 deficiencies on RV1B-induced
type I and type III IFNresponses
Our previous studies in cultured airway epithelial cells
demonstrated that MDA5 and TRIF, the adaptor protein for
TLR3, are required for maximal RV-induced IFN expression.
However, while the airway epithelium is a major target of RV
infection, other cell types such as monocytes and macrophages
may also be infected [18]. To determine whether MDA5 and
TLR3 are required for RV1B-induced airway IFN responses in
vivo, we studied MDA52/2 mice, TLR32/2 mice, and their
strain-matched controls. Mice were inoculated intranasally with
sham HeLa cell lysate, replication-deficient UV-irradiated RV1B
or intact RV1B. Lungs were harvested at 4–96 h after infection.
RV1B infection caused a significant induction of the expression of
type I IFNs (IFN-a and IFN-b) in control mice compared to sham
or UV-RV1B inoculated mice. However, MDA52/2 mice
showed minimal type I IFN responses 4 and 24 h post-infection
(Figures 1a, 1b). The IFN-b protein response 24 h after infection
was also significantly decreased in MDA52/2 mice compared to
control mice (Figure 1e). Interestingly, by 48 h post infection,
when the type I IFN expression in RV1B-infected control mice
was essentially over, MDA52/2 mice showed robust but delayed
type I IFN response. In contrast, the expression of type III IFNs
(IFN-l2 and IFN-l3) in RV1B-infected MDA52/2 mice was
significantly lower than that of control mice throughout the time
course studied (Figures 1c, 1d). These data suggest that the
regulation of type I and type III IFN differ in the context of RV
infection.
In contrast to MDA5 null mice, there was no difference in type I
IFNs or type III IFNs expression between TLR32/2 mice and
controls (Figures S1a–e). IFNs-a,- b,- l2 and -l3 each showed
brisk responses following RV1B infection of TLR32/2 mice.
Taken together, these data suggest that both type I and type III
IFNs are partially dependent on MDA5, but not TLR3, for their
induction.
MDA5 regulates viral titer
To determine whether MDA5 plays a role in viral clearance, we
determined lung viral titer and copy number by plaque assay and
qPCR, respectively. As we have observed previously, control mice
showed a modest increase in lung viral titer and copy number 24 h
after infection [17], indicating a small amount of viral replication.
There was also a small but statistically significant increase in viral
titer and copy number in MDA52/2 mice compared to that of
control mice 24 h post infection (Figures 2a, 2b). Viral titer and
copy number were not significantly different between the two
groups at 48 h. Thus, MDA52/2 mice demonstrate a transient
increase in infectious virus, perhaps due to the delayed type I and
reduced type III IFN response.
There was no difference in viral titer or copy number between
the control and TLR32/2 mice (Figures S2a, S2b). The absence
of a change in viral load is consistent with the normal IFN
response observed in TLR32/2 mice.
MDA5 and TLR3 signaling are each required for
RV1B-induced inflammatory responses
To determine whether MDA5 and TLR3 play a role in
mediating RV1B-induced inflammatory responses, we measured
the expression of pro-inflammatory cytokines in MDA52/2
mice, TLR32/2 and their controls. RV1B-infected MDA52/2
mice and TLR32/2 mice each displayed significantly decreased
expression of the neutrophil chemoattractants CXCL1/KC and
CXCL2/MIP-2 compared to that of control mice (Figures 3a–d).
CXCL1 protein was also decreased (Figures 3e, 3f). To varying
degrees, CCL2/MCP-1, CXCL10/IP-10 and eotaxin-1/CCL11
were also decreased in the MDA5 and TLR3 knockout mice
(Figure 4a–f). Accordingly, we also found less inflammation in the
lungs of RV1B-infected MDA52/2 and TLR32/2 mice
compared to control mice 24 h after infection (Figure 5a, 5b).
There were significantly fewer neutrophils in the lungs of RV1B-
infected MDA52/2 and TLR32/2 mice compared to control
Author Summary
Rhinovirus (RV) is the most frequent cause of acute
respiratory tract infection in humans. RV has emerged as
the most frequent pathogen associated with exacerbations
of asthma. However, the mechanisms by which RV causes
asthma flare-ups are not precisely known. We studied the
requirements of two receptors which bind viral double-
stranded RNA, melanoma differentiation-associated gene
(MDA)-5 and Toll-like receptor (TLR)-3, for RV-induced
airway responses using specific knockout mice. We found
that MDA5 and TLR3 deficiencies had modest effects on
viral titer. However, MDA5 and TLR3 knockout mice
showed significantly reduced airway inflammation and
responsiveness in response to RV infection. Mice with
allergic airways disease also showed reduced airway
responses. These results suggest that, in the context of
RV infection, TLR3 and MDA5 initiate pro-inflammatory
signaling pathways which lead to airways inflammation
and hyperresponsiveness.
MDA5 and Rhinovirus-Induced Airway Inflammation
PLoS Pathogens | www.plospathogens.org 2 May 2011 | Volume 7 | Issue 5 | e1002070Figure 1. RV1B-induced expression of type I and III IFNs in MDA52/2 mice. MDA52/2 and their control mice were inoculated with sham,
UV-irradiated RV1B (UV RV1B) or intact RV1B. Lungs were harvested at 4, 24, 48, and 96 h after infection. A–D. The expression of IFN-a, IFN-b, IFN-l2
and IFN-l3 at each time point was determined by qPCR. E. IFN-b protein production was measured by ELISA at 24 h post-infection. The expression of
each target gene was normalized to GAPDH. Data represent mean6SEM for 3–7 mice.
doi:10.1371/journal.ppat.1002070.g001
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PLoS Pathogens | www.plospathogens.org 3 May 2011 | Volume 7 | Issue 5 | e1002070mice (Figures 6a, 6b). These data suggest that MDA5 and TLR3
are each required for maximal RV1B-induced inflammatory
responses in vivo.
MDA5 and TLR3 are each required for RV1B-induced
airway hyperresponsiveness
We have previously shown that RV1B-induced airways
cholinergic hyperresponsiveness in naı ¨ve (non-allergic) mice is
dependent on CXCR2 and airway neutrophilic inflammation
[19]. Since RV1B-infected MDA52/2 and TLR32/2 mice
each showed significant reductions in lung neutrophils and the
CXCR2 ligands CXCL1 and CXCL2, we hypothesized that
RV1B-infected knockout mice would show reduced airway
responses to methacholine compared to control mice. As noted
previously, RV1B-infected control mice displayed significantly
higher airways responses to methacholine compared to sham-
infected mice (Figures 6c, 6d). However, compared to sham-
inoculated mice, RV1B-induced airway responses were not
elevated in MDA52/2 and TLR32/2 mice. Together, these
results demonstrate that MDA5 and TLR3 signaling initiates pro-
inflammatory signaling pathways leading to airways inflammation
and hyperresponsiveness. Thus, MDA5- and TLR3-driven innate
immune responses to RV are responsible for airway dysfunction in
this model.
Figure 2. RV1B titer and copy number in MDA52/2 mice. MDA52/2 and their control mice were infected with RV1B. Lungs were harvested
at 4, 24, 48, and 96 h after infection. A. Lung titer at 24 h post-infection was determined by plaque assay. B. RV1B copy number at each time point
was determined by qPCR. RV copy number was normalized to 18S rRNA. Data represent mean6SEM for 3–7 mice (*p,0.05, one-wayANOVA).
doi:10.1371/journal.ppat.1002070.g002
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PLoS Pathogens | www.plospathogens.org 4 May 2011 | Volume 7 | Issue 5 | e1002070MDA5 is required for maximal RV1B-induced type I and III
IFN responses in mice with allergic airways disease
Since RV is the most frequent pathogen associated with asthma
exacerbations, we sought to examine the effect of MDA5
deficiency, which affected both RV-induced inflammatory and
IFN responses, on mice that were sensitized and challenged with
ovalbumin (OVA), a commonly-used model of allergic airways
disease. Wild-type and MDA52/2 mice were injected intraper-
itoneally with PBS or a solution of alum and OVA, and then
challenged intranasally with PBS or OVA. Mice were infected
Figure 3. RV1B-induced chemokine expression in MDA52/2 and TLR32/2 mice. MDA52/2, TLR32/2 and their strain control mice were
inoculated with sham, UV-irradiated RV1B (UV RV1B) or intact RV1B. Lungs were harvested 24 h after infection. A–D. The expression of CXCL1/KC,
CXCL2/MIP-2, CCL2/MCP-1, CXCL10/IP-10 and CCL11/eotaxin-1 was determined by qPCR. E–F. Protein production of CXCL1/KC and CXCL2/MIP-2 was
measured by ELISA and bioplex assay. The expression of each target gene was normalized to GAPDH. Data represent mean6SEM for 3–7 mice
(*p,0.05, one-way ANOVA).
doi:10.1371/journal.ppat.1002070.g003
MDA5 and Rhinovirus-Induced Airway Inflammation
PLoS Pathogens | www.plospathogens.org 5 May 2011 | Volume 7 | Issue 5 | e1002070with RV1B immediately following the last OVA or PBS treatment.
Lung inflammatory and IFN responses were measured as
previously described in non-allergic, naı ¨ve mice. Twenty-four h
after infection, RV1B-infected OVA-treated wild-type mice
displayed significantly increased levels of IFN-b, IFN-l2 and
IFN-l3 expression compared to sham-inoculated OVA-treated
Figure 4. RV1B-induced pro-inflammatory cytokine expression in MDA52/2 and TLR32/2 mice. MDA52/2, TLR32/2, and their strain
control mice were inoculated with sham, UV-irradiated RV1B (UV RV1B) or intact RV1B. Lungs were harvested 24 h after infection. A–F. The expression
of CXCL1/KC, CXCL2/MIP-2, CCL2/MCP-1, CXCL10/IP-10 and CCL11/eotaxin-1 was determined by qPCR. The expression of each target gene was
normalized to GAPDH. Data represent mean6SEM for 3–7 mice (*p,0.05, one-way ANOVA).
doi:10.1371/journal.ppat.1002070.g004
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OVA-treated MDA52/2 mice (Figures 7a–c). Consistent with
our previous results [18], after ovalbumin sensitization and
challenge, both control and MDA52/2 mice showed signifi-
cantly lower viral titers compared to non-allergic mice,
indicating either enhanced viral clearance or perhaps a failure
of the virus to establish infection (Figure 7d). However, there
was no difference observed between OVA-treated control or
MDA52/2 mice with respect to viral titers. Thus, in the
context of allergic inflammation, MDA5-deficient mice showed
reduced viral titers, similar to wild-type mice, despite an
abnormal IFN response.
MDA5 is required for maximal RV1B-induced airways
inflammation and hyperresponsiveness in mice with
allergic airways disease
We have previously shown that RV1B infection and OVA
sensitization and challenge have additive effects on lung
inflammation in control mice one day after infection [18]. Thus,
Figure 6. Airway inflammation and responsiveness in RV1B-infected MDA52/2 and TLR32/2 mice. MDA52/2, TLR32/2, and their
control mice were infected with RV1B. Twenty-four h after infection, RV1B-induced neutrophil infiltration was determined in MDA52/2 mice (A) and
TLR32/2 mice (B) along with their respective controls. Data represent mean6SEM for 3–7 mice, *p,0.05, one-way ANOVA). Total respiratory system
resistance of MDA52/2 (C) and TLR32/2 (D) mice were determined by plethysmography. Data represent mean6SEM for 3–7 mice (*p,0.05, two-
way ANOVA).
doi:10.1371/journal.ppat.1002070.g006
Figure 5. Airway inflammation in RV1B-infected MDA2/2 and TLR32/2 mice. MDA52/2 (A), TLR32/2 (B) and their control mice were
infected with RV1B. Twenty-four h after infection, lungs were fixed and stained with hematoxylin and eosin (original magnification, 1006).
doi:10.1371/journal.ppat.1002070.g005
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more lung inflammation than sham-infected or RV1B-infected
naı ¨ve wild-type mice. Baseline levels of cytokines (CXCL2/MIP-2,
CXCL1/KC, IL-6, CCL2/MCP-1, IFN-c and CCL11/eotaxin-1)
were increased in the lungs of sham-infected OVA-treated mice
(Figure 8) compared to the naı ¨ve, non-allergic mice (Figures 4a, 4c,
S3). Twenty-four h after RV1B infection, CXCL1/KC, CXCL2/
MIP-2, IL-6, CCL2/MCP-1 and IFN-c expression in wild-type
mice increased 3–5 fold. MDA5 deficiency significantly reduced
the induction of CXCL1/KC, CXCL2/MIP-2, IL-6, CCL2/
MCP-1 and IFN-c. The expression of CCL11/eotaxin-1 mRNA
was not significantly elevated 24 h after infection and was not
different between control and MDA52/2 mice (Figure 8f).
Neutrophil infiltration in the MDA52/2 mice was significantly
lower than wild-type mice (Figures 9a, 9b). Hematoxylin and eosin
staining showed less inflammation around the airways of RV1B-
infected OVA-treated MDA52/2 mice compared to RV-infected
OVA-treated wild-type mice. In contrast, there was no significant
difference observed in the number of macrophages, eosinophils or
lymphocytes (Figure S4). Consistent with the greater amount of
inflammation present in the lung, RV1B-infected, OVA-treated
control mice displayed the highest airways responsiveness
compared to any other treatment, and MDA5 deficiency
essentially eliminated this hyperresponsiveness (Figure 9c).
Ninety-six h after infection, RV1B-induced airways hyperrespon-
siveness is dependent on CCL11/eotaxin-1-mediated eosinophilic
Figure 7. RV1B-induced IFN responses and viral titer in OVA-treated MDA52/2 mice. OVA-treated MDA52/2 mice and control mice were
infected with sham or RV1B. Total lungs were harvested at 24 post infection. A–C The expression of IFN-b, IFN-l2, IFN-l3 was determined by qPCR. D.
Total lung titer at 24 h post infection was determined by plaque assay. The expression of each target gene was normalized to GAPDH. Data represent
mean 6 SEM for five-seven mice.
doi:10.1371/journal.ppat.1002070.g007
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PLoS Pathogens | www.plospathogens.org 9 May 2011 | Volume 7 | Issue 5 | e1002070Figure 8. RV1B-induced pro-inflammatory cytokine expression in OVA-treated MDA52/2 mice. OVA-sensitized and -challenged
MDA52/2 and control mice were inoculated with sham or RV1B. Lungs were harvested at 24 and 96 h after infection. A–F. The expression of CXCL1/
KC, CXCL2/MIP-2, IL-6, CCL2/MCP-1, IFN-c and CCL11/eotaxin-1 was determined by qPCR. The expression of each target gene was normalized to
GAPDH. Data represent mean6SEM for 4–7 mice (*p,0.05, one-way ANOVA).
doi:10.1371/journal.ppat.1002070.g008
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PLoS Pathogens | www.plospathogens.org 11 May 2011 | Volume 7 | Issue 5 | e1002070airway inflammation [18]. At this time point, in contrast to the other
cytokines, IFN-c mRNA expression increased in both control and
MDA52/2 mice (Figures 8e). Also, compared to control mice,
RV1B-induced IL-6 and CCL11/eotaxin-1 levels were significantly
decreased in MDA52/2 mice (Figures 8c, 8f). No differences in
neutrophil, lymphocyte or macrophage infiltration between wild-type
andMDA5nullmicewereobserved(FigureS5).However,eosinophil
infiltration was significantly lower in MDA52/2 mice (Figure 9d).
Finally, the airways responsiveness of RV1B-infected OVA-treated
MDA52/2 mice was decreased at 96 h post-infection (Figure 9e).
TLR3 is required for maximal RV1B-induced airways
responses in mice with allergic airways disease
We also tested the effects of TLR3 knockout on RV1B-induced
airways inflammation and responsiveness in OVA-sensitized and -
challenged mice. As with mice unexposed to OVA, there was no
effect of TLR3 knockout on RV1B-induced IFN-b, IFN-l2o r
IFN-l3 mRNA levels (Figures 10a, 10b, S6). As in our
experiments with MDA5 null and control mice, OVA sensitization
and challenge was associated with a reduction in viral titer
(Figure 10c). RV1B-induced infiltration of neutrophils and
macrophages into the lungs of OVA-treated TLR32/2 mice
was significantly lower than wild-type mice (Figures 10d, 10e).
There was no effect of TLR3 knockout on day 1 lymphocytes or
eosinophils (Figure S6) or day 4 cell counts (not shown). RV1B-
infected, OVA-sensitized and -challenged mice with TLR3
deficiency demonstrated significantly lower airways responsiveness
to inhaled methacholine one day after infection than similarly-
infected and -treated wild-type mice (Figure 10f). By day 4, there
was no difference in airways responsiveness between groups
(Figure S6).
Consistent with the lower number of neutrophils in the lungs of
TLR3 knockout mice, mRNA expression of the neutrophil
chemokine CXCL1/KC was decreased one day after RV1B
infection (Figure 11a). CXCL2, CCL2 and IFN-l levels were also
decreased to varying degrees one day after infection (Figure 11c–
e). Together, these data suggest that, in mice with allergic airways
disease, TLR3 signaling initiates pro-inflammatory responses
which augment airways cholinergic responsiveness. On the other
hand, four days after infection, TLR32/2 mice showed
significantly increased mRNA expression of IL-6, CCL2, CCL11
and IFN-l (Figures 11c–f).
Discussion
Pattern recognition receptors regulate multiple effector mole-
cules, including type I IFNs and other pro-inflammatory cytokines
[20,21,22]. The innate immune response to viral infection is
specific to cell type/organ as well as to invading pathogen [23,24].
The ultimate host response is likely to be an integration of both
IFN and pro-inflammatory responses. Because viral infections, in
particular RV, are the most common cause of asthma exacerba-
tions, we examined the roles of the pattern recognition receptors
TLR3 and MDA5 in the response to RV infection. We found that
both TLR3 and MDA5 were required for RV1B-induced
maximal inflammatory responses and airways cholinergic hyper-
responsiveness in vivo. MDA5 mice also showed a delayed type I
IFN and attenuated type III IFN response to RV1B infection,
leading to a transient increase in viral titer. Further, MDA5 null
mice with allergic airways disease showed reduced viral titers
compared to non-allergic mice despite deficient IFN responses,
and allergic MDA5 and TLR3 null mice each showed decreased
RV-induced airway inflammatory and contractile responses.
Together, these results suggest that TLR3 and MDA5 individually
initiate pro-inflammatory signaling pathways leading to airways
inflammation and cholinergic hyperresponsiveness.
Mice lacking TLRs have been shown to display diverse viral
infectious phenotypes depending on the host gene-pathogen
combination. Studies have shown that TLR3 plays a protective role
against various viral infections in vivo. Mice lacking TLR3 display
reduced IFN-a/b production and an increased viral load against
mouse cytomegalovirus infection [25]. In response to coxsackievirus
B4 infection, TLR32/2 mice produce less pro-inflammatory
mediators and are unable to control viral replication at the early
stages of infection, resulting in severe cardiac damage and reduced
survival [26]. Compared to wild-type mice, TLR32/2 mice show
increasedairwaymucus,airwaysresponsivenessandIL-13expression
with RSV infection [27], suggesting that TLR3 signaling may be
protective against airway pathology with this virus. On the other
hand, other studies have suggested that TLR3 plays a detrimental
role upon viral infection. Despite an increased viral load, influenza A
virus-infected TLR32/2 animals display significantly reduced
pro-inflammatory mediators, suggesting that TLR3 critically con-
tributes to a detrimental host inflammatory response [28]. In
addition, TLR3 signaling has also been reported to have a
detrimental effect in phlebovirus and vaccinia infections [29,30].
TRIF2/2 mice challenged with dsRNA display decreased airway
responsiveness and pulmonary inflammation compared to control
mice [31]. The precise role of TLR3 in West Nile virus infections is
uncertain [32,33]. Our study demonstrated that, as with influenza
infection, TLR32/2 mice display decreased airway neutrophilic
inflammation upon RV1B infection, resulting in a significantly lower
airways cholinergic responsiveness, suggesting for the first time that
TLR3 signaling is responsible for airway dysfunction following RV
infection.
In contrast to the effect of TLR3 deficiency on airways
inflammation, TLR3 null mice showed normal IFN production.
However, MDA52/2 mice displayed a reduction in type I IFN
expression after RV1B infection, leading to a transient increase in
viral load and copy number 24 h after infection. MDA52/2 mice
displayed increased IFN-a/b expression 48 h after RV1B infection,
suggesting a delayed onset of IFN signaling. We speculate that this
was due to either the compensatory activation of another host
pattern recognition receptor, or the dysregulation of normal innate
immune system activation in the absence of MDA5-mediated
signaling. On the other hand, MDA5 null mice showed a persistent
defect in the expression of type III IFNs. These data suggest that
type III IFN responses are a less critical host defense against RV1B
infection and are regulated independently of type I IFN responses.
In support of this concept, IFN-l is not required for immunity to
influenza in wild-type mice, though it protects influenza-infected
IFN-a/b knockout mice [34], suggesting that type III IFNs play a
Figure 9. Lung inflammation in OVA-treated RV1B-infected MDA52/2 mice: histology and airways responsiveness. MDA52/2 mice
and their control mice were sensitized and challenged with OVA and then infected with RV1B. A. Twenty-four h after infection, lungs were fixed and
stained with hematoxylin and eosin (original magnification, 1006). B. Twenty-four h after infection, lungs were digested by collagenase. The number
of infiltrated neutrophils were counted. C. Total respiratory system resistance one day after infection was determined by plethysmography. D. Four
days after infection, MDA5 null mice showed significantly reduced lung eosinophils. E. Total respiratory system resistance four days after infection.
Data represent mean6SEM for 6 mice (*p,0.05, two-way ANOVA).
doi:10.1371/journal.ppat.1002070.g009
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PLoS Pathogens | www.plospathogens.org 12 May 2011 | Volume 7 | Issue 5 | e1002070Figure 10. Airway responses in RV1B-infected, OVA-sensitized and -challenged TLR3 null mice. A, B. mRNA expression of IFN-b and IFN-
l2 24 and 96 h after infection was determined by qPCR. The expression of each target gene was normalized to GAPDH. C. Viral titer measured 24 h
after RV1B infection of allergic wild-type and TLR32/2 mice. D, E. Lungs were digested by collagenase and the number of infiltrated neutrophils and
macrophages were counted. F. Total respiratory system resistance one day after infection was determined by plethysmography. Data represent
mean6SEM for 4 mice (*different from wild-type RV1B-infected mice, p,0.05, one- or two-way ANOVA; {different from sham-inoculated mice,
p,0.05, one-way ANOVA).
doi:10.1371/journal.ppat.1002070.g010
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Together, these data suggest that MDA5 rather than TLR3 is the
primary receptor responsible for the initial IFN response to RV
infection, and that type I IFNs play a role in the containment of RV
infection.
In addition to decreased IFN responses, MDA52/2 mice also
displayed reduced expression of pro-inflammatory cytokines such
as CXCL1, CXCL2, CCL2 and IL-6. The coupling of IFN and
pro-inflammatory responses in MDA5-deficient mice has been
observed in other studies. Bone marrow-derived dendritic cells
from MDA52/2 mice display significantly lower expression of
IFN-a, CCL2/MCP-1 and IL-6 against murine norovirus
infection compared those from control mice [23]. On the other
hand, reduced viral clearance has ultimately led to enhanced
inflammatory responses in some models. MDA52/2 mice show
significantly decreased IFN mRNA expression profiles five days
after Sendai virus infection but compensatory IL-6 mRNA
expression, resulting in increased mortality and severe histopath-
ological changes in the lower airways [35]. Thus, host inflamma-
tory responses in the absence of IFN expression are pathogen-
specific: When challenged by pathogenic lethal viruses such as
Sendai virus, the host initiates inflammatory responses to defend
against viral invasion. However, when confronted with non-
pathogenic viruses such as RV, it may be advantageous for the
host to terminate the inflammatory response, in order to avoid
adverse effects.
It has been proposed that asthmatics are susceptible to RV
infection due to deficient IFN production. RV-infected airway
epithelial cells from asthmatic subjects show impaired production
of IFN-b and -l [13,14] and asthmatics experimentally infected
with RV16 showed a reduced IFN-c/IL-5 mRNA ratio in their
sputum [15]. To examine whether an allergic background alters
the response of wild-type and MDA5 knockout mice to viral
infection, we combined RV infection with a commonly-used
model of allergic airways disease, OVA-sensitization and chal-
lenge. First, we found that, following OVA treatment, both wild-
type and MDA52/2 mice demonstrated reduced viral titers
following infection with RV. MDA5 null mice showed reduced
viral titers despite attenuated IFN responses. This finding is
consistent with our previous data [18], as well as data from guinea
pigs that were sensitized to OVA and subsequently infected with
parainfluenza [36]. The precise mechanism for decreased viral
titers in mice with allergic airways disease is unclear. Prior to RV
infection, these mice showed increased baseline levels of
neutrophils, macrophages, lymphocytes, eosinophils, IFN-c, IL-6
and CCL11/eotaxin-1, each of which could have contributed to
an antiviral response. Eosinophils are known to contain granule
proteins such as eosinophil cationic protein and eosinophil-derived
neurotoxin,which possess strong ribonuclease activity that can
neutralize viruses [37]. Eosinophils have been shown to neutralize
RSV in a concentration-dependent manner, and this effect could
be completely reversed by a ribonuclease inhibitor [38,39].
Another possible mediator is nitric oxide, an antiviral which is
produced by epithelial cells in response to RV infection [40].
Whatever the mechanism, our finding of reduced viral titers in
MDA52/2 mice with attenuated IFN responses demonstrates
that other factors besides IFNs may play a role in the containment
and clearance of RV infection.
Second,wefoundthatRV1B-infectedOVA-treatedMDA52/2
mice showed significantly reduced IFN and cytokine levels
compared to wild-type mice. Reduced cytokine expression, in turn,
led to persistent attenuations in airway inflammation and
responsiveness. Thus, pro-inflammatory and IFN responses were
strictly linked: Reduced IFN responses in MDA52/2 mice were
associated with less robust, not increased, inflammatory responses.
These data are consistent with our recent findings in airway
epithelial cells isolated from patients with COPD [41]. These cells
showed increases in both pro-inflammatory cytokines and IFNs.
In general, TLR3-deficient mice with allergic airways disease
showed similarly attenuated inflammatory responses to RV1B
infection, leading to reduced airways responsiveness. However,
there were some differences between MDA5 and TLR3 null mice.
As with non-allergic mice, TLR3 knockout mice showed normal
IFN responses to RV infection. In addition, TLR3 mice showed
higher levels of some pro-inflammatory cytokines four days after
infection, consistent with compensatory activation of another host
pattern recognition receptors. On the other hand, a recent study
showed that administration of synthetic dsRNA attenuates allergic
inflammation [42], suggesting that TLR3 signaling may also have
anti-inflammatory effects. Finally, disparities between MDA5 and
TLR3 null mice be attributed to differences in genetic back-
ground.
Finally, we would like to add a few comments about our mouse
model of human RV1B infection. We [17] and others [43] have
found that a much higher viral titer is required to infect mice
compared to humans. This is to be expected, as differences in the
homology of viral receptors and intracellular signaling mecha-
nisms are likely to restrict viral infection and replication in mice.
This restriction in viral replication could have limited the effects of
pattern recognition receptor knockout in our model. For example,
had viral replication been more robust, it is conceivable that TLR3
and MDA5 knockout could have led to more severe airways
disease, rather than the attenuated responses we observed. On the
other hand, we suspect our results are physiologic, for the
following reasons: First, viral replication in the lungs of humans is
likely to be small. Despite the fact that RV is a well-established
cause of asthma and COPD exacerbations in humans, it has rarely
been cultured from the lower airways of non-immunosuppressed
patients. Second, RV causes minimal cytotoxicity in infected
epithelial cells. Whatever the level of viral replication, our results
demonstrate that engagement of TLR3 and MDA5 by RV
dsRNA initiates pro-inflammatory signaling pathways leading to
airways inflammation and cholinergic hyperresponsiveness. To
our knowledge this is the first study to examine the contribution of
TLR3 and MDA5 to RV responses in vivo.
Our data raise the possibility that TLR3- and MDA5-driven
innate immune responses to RV, a relatively non-pathogenic virus,
are maladaptive, at least at the onset of infection. If this were true
in humans, then antagonists against TLR3 and MDA5 could
provide potential therapeutic agents in the treatment of virus-
induced asthma exacerbations. Future studies focusing on the
interactions and coordination between the two receptors would be
Figure 11. RV1B-induced pro-inflammatory cytokine expression in OVA-treated TLR32/2 mice. OVA-sensitized and -challenged TLR32/
2 and control mice were inoculated with sham or RV1B. Lungs were harvested at 24 and 96 h after infection. A–F. The expression of CXCL1/KC,
CXCL2/MIP-2, IL-6, CCL2/MCP-1, IFN-c and CCL11/eotaxin-1 was determined by qPCR. The expression of each target gene was normalized to GAPDH.
Data represent mean6SEM for 4 mice (*different from wild-type RV1B-infected mice, p,0.05, one-way ANOVA; {different from sham-inoculated
mice, p,0.05, one-way ANOVA).
doi:10.1371/journal.ppat.1002070.g011
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pattern recognition receptor-mediated innate immune responses.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of the University of Michigan Medical School. All
surgery was performed under sodium pentobarbital anesthesia,
and all efforts were made to minimize suffering.
Animals
A breeding pair of MDA52/2 mice, developed on a .99.5%
C57BL/6 background, was generously provided by Dr. Marco
Colonna (Washington University, St. Louis) [23]. Mice were then
bred at the University of Michigan animal facility. Control
C57BL/6J mice were purchased from Jackson Laboratories.
TLR32/2 and B6;129SF2/J control mice were also purchased
from Jackson Laboratories (Bar Harbor, MA). Six-to-eight week
old female mice were used in this study. All mice were housed in a
specific pathogen-free area within the animal care facility.
Generation of RV and titer determination
RV1B (ATCC, Manassas, VA) was concentrated, purified and
titered as described previously [44,45]. Viral titer was determined
by plaque assay [46]. To produce replication-deficient virus,
RV1B was UV-irradiated using a CL-1000 crosslinker (UVP,
Upland, CA).
RV exposure and ovalbumin (OVA) sensitization/
challenge
Mice were inoculated intranasally with 45 mlo f1 610
8
TCID50/ml RV1B, UV-irradiated RV or an equal volume sham
HeLa cell lysate [17]. For OVA sensitization, mice were injected
intraperitoneally on days 1 and 7 with 0.2 ml PBS or a solution of
alum and 100 mg endotoxin-free OVA (Sigma-Aldrich, St. Louis,
MO). Next, mice were challenged intranasally with 50 ml of PBS
or 100 mg OVA on days 14, 15 and 16. Selected mice were
infected with RV1B immediately following the last OVA or PBS
treatment.
Lung inflammation
To quantify inflammatory cells, lung digests were obtained by
mincing the tissue, proteolysis in collagenase type IV (Gibco
Invitrogen, Carlsbad, CA) and straining through a 70 mm nylon
mesh (BD Falcon, San Jose, CA), as described [47]. The resulting
pellet was treated with red blood cell lysis buffer (BD Pharmingen,
San Diego, CA) and leukocytes were enriched by spinning the cells
through 40% Percoll (Sigma-Aldrich). The total cell count was
determined on a hemocytometer. Cytospins were performed from
lung digested leukocytes and were then stained by Diff-Quick
method (Dade Behring, Newark, DE). Differential counts were
determined by counting 200 cells per slide.
Measurement of airways responsiveness
Mice were anesthetized with sodium pentobarbital (50 mg/kg
mouse, intraperitoneal injection) and a tracheostomy performed.
Mechanical ventilation was performed and total respiratory system
measured using a Buxco FinePointe operating system (Wilming-
ton, NC). Airway responsiveness was assessed by measuring
changes in resistance in response to increasing doses of nebulized
methacholine, as described [17].
Histology
Lungs were fixed in 10% formalin at an inflation pressure of
30 cmH2O overnight, transferred to 70% ethanol and paraffin
embedded. Five m sections were stained with hematoxylin and
eosin.
Cytokine/chemokine expression
Total lung RNA was extracted using the RNeasy kit (Qiagen,
Alameda, CA) and then transcibed to first-strand cDNA using
Taqman reverse transcription reagents (Applied Biosystems Life
Technologies, Carlsbad, CA). First-strand cDNA was then used to
quantify the expression of IFN-a, IFN-b, IFN-l2, IFN-l3, IFN
response factor (IRF)-7, CXCL10/IP-10, IFN-c, CXCL1/KC,
CXCL2/MIP-2, CCL2/MCP-1, and CCL11/eotaxin-1 by quan-
titative two-step real time PCR using specific Syber green primers.
All primers were designed and purchased from IDT (Coralville,
IA).
Cytokine production
Lungs were homogenized in 1 ml PBS with protease inhibitor
cocktail, spun for 15 minutes at 1500 g, and the supernatant
assayed for CXCL1, CXCL2 and IFN-b by ELISA (R&D
Systems, Minneapolis, MN; PBL InterferonSource, Piscataway,
NJ).
Presence of viral RNA
RNA was extracted from lungs of mice using Trizol reagent
(Sigma-Aldrich, St. Louis, MO) and analyzed for the presence of
viral RNA by reverse transcriptase-PCR. Quantitative one-step
real time PCR for positive-strand viral RNA was conducted using
RV-specific primers and probes (forward primer: 59-GTG AAG
AGC CSC RTG TGC T-39; reverse primer: 59-GCT SCA GGG
TTA AGG TTA GCC-39; probe: 59-FAM-TGA GTC CTC
CGG CCC CTG AAT G-TAMRA-39 [14]. Copy numbers of
positive strand viral RNA were normalized to 18S RNA, which
was similarly amplified using gene-specific primers and probes.
Data analysis
Mice from each experimental group were studied in 2–4
separate experiments. SigmaStat computing software (SPSS,
Chicago, IL) was used for data analysis. Data are represented as
mean6SEM. Statistical significance was assessed by one- or two-
way analysis of variance (ANOVA). Differences identified by
ANOVA were pinpointed by the Student Newman-Keuls’
multiple range test.
Supporting Information
Figure S1 RV1B-induced expression of type I and III IFNs in
TLR32/2 mice. TLR32/2 and their control mice were
inoculated with sham, UV-irradiated RV1B (UV RV1B) or intact
RV1B. Lungs were harvested at 4, 24, 48, and 96 h after infection.
A–D. The expression of IFN-a, IFN-b, IFN-l2 and IFN-l3a t
each time point was determined by qPCR. E. IFN-b protein
production was measured by ELISA at 24 h post-infection. The
expression of each target gene was normalized to GAPDH. Data
represent mean6SEM for 3–7 mice.
(TIF)
Figure S2 RV1B titers and viral RNA levels in control and
TLR32/2 mice. TLR32/2 and their control mice were
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PLoS Pathogens | www.plospathogens.org 16 May 2011 | Volume 7 | Issue 5 | e1002070infected with RV1B. Lungs were harvested at 4, 24, 48, and 96 h
post infection. A. Total lung titer at 24 h post-infection was
determined by plaque assay. B. RV1B copy number at each time
point was determined by qPCR. RV copy number was normalized
to 18S rRNA. Data represent mean6SEM for 3–7 mice.
(TIF)
Figure S3 RV1B-induced IL-6 and IFN-c expression in
MDA52/2 mice. MDA52/2 and their control mice were
inoculated with sham, UV-irradiated RV1B (UV RV1B) or
RV1B. Lungs were harvested 24 after infection. A–B. The
expression of IL-6 and IFN-c were determined by qPCR. The
expression of each target gene was normalized to GAPDH. Data
represent mean6SEM for 3–7 mice.
(TIF)
Figure S4 Early lung macrophage, eosinophil and lymphocyte
counts in OVA-treated RV1B-infected MDA52/2 mice.
MDA52/2 mice and their control mice were sensitized and
challenged with OVA and then infected with RV1B. Twenty-four
h after infection, lungs were digested by collagenase. A–C. The
numbers of infiltrated macrophages, eosinophils, lymphocytes
were counted. Data represent mean6SEM for 6 mice.
(TIF)
Figure S5 Late lung neutrophil, lymphocyte and macrophage
counts in OVA-treated RV1B-infected MDA52/2 mice: histol-
ogy and airways responsiveness. MDA52/2 mice and their
control mice were sensitized and challenged with OVA and then
infected with RV1B. Ninety-six h after infection, lungs were
digested by collagenase. A–C. The numbers of infiltrated
neutrophils, lymphocytes, and macrophages were counted. Data
represent mean6SEM for 4–7 mice.
(TIF)
Figure S6 Cell counts, IFN-l3 mRNA levels and late airways
responsiveness in OVA-treated RV1B-infected TLR32/2 mice.
TLR32/2 mice and their control mice were sensitized and
challenged with OVA and then infected with RV1B. A, B.
Twenty-four h after infection, lungs were digested by collagenase
and the numbers of infiltrated lymphocytes and eosinophils
counted. C. The mRNA expression of IFN-l3 was determined
by qPCR. Expression was normalized to GAPDH. D. Airway
cholinergic responsiveness 96 h after RV1B infection. Data
represent mean6SEM for 4 mice.
(TIF)
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